Retinoids in cancer chemoprevention. Clinical trials with the synthetic analogue fenretinide

Ann N Y Acad Sci. 1995 Sep 30;768:148-62. doi: 10.1111/j.1749-6632.1995.tb12118.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Anticarcinogenic Agents / adverse effects
  • Anticarcinogenic Agents / therapeutic use*
  • Breast Neoplasms / epidemiology
  • Breast Neoplasms / prevention & control*
  • Carcinoma, Basal Cell / prevention & control*
  • Cell Differentiation
  • Cell Division
  • Clinical Trials as Topic
  • Female
  • Fenretinide / adverse effects
  • Fenretinide / therapeutic use*
  • Head and Neck Neoplasms / prevention & control
  • Humans
  • Incidence
  • Leukoplakia, Oral / prevention & control*
  • Models, Biological
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Urinary Bladder Neoplasms / prevention & control*

Substances

  • Anticarcinogenic Agents
  • Fenretinide